Semaglutide: GLP-1 Receptor Activation
Semaglutide mimics GLP-1 hormones to delay gastric emptying and reduce hypothalamic hunger signaling, enabling a 20-30% caloric deficit without cravings. This FDA-approved medication creates a metabolic environment primed for fat loss while preserving lean tissue.
- Reduces hunger signals from your brain
- Slows digestion, keeping you fuller longer
- Creates sustainable caloric deficit without willpower
- Average weight loss: 15-20% of body weight